TR-C 19 / VSY Biotech - LARVOL DELTA

A new drug to treat Covid-19, TR-C 19 is now ready for human testing (PRNewswire) - "VSY Biotechnology GmbH is very excited to announce a new drug, named TR-C 19, has been developed to treat COVID-19 by the VSY Biotechnology R&D team....Drug is now at the authority approval stage for usage on voluntary COVID-19 patients and clinical trial. Health authorities accelerate their evaluation of TR-C 19 considering public health emergency conditions....Clinical and voluntary trials will be organized in partnership with SBU. The initial results of voluntary patient trials will be shared publicly in the coming weeks."

Clinical data • Regulatory • Infectious Disease • Novel Coronavirus Disease